Women navigating the challenges in the lead-up to menopause and beyond know the journey can be both physically and emotionally transformative. For years, conversations around this topic have been dominated by discussions of hot flushes and mood swings, leaving other important aspects overlooked. Now, a groundbreaking innovation, Myregyna, from Weir Science, is set to change that – and Kiwi actress Robyn Malcolm has joined the mission to make sure women everywhere hear about it.
At the heart of this change is Dr Iona Weir PhD, a trailblazing scientist and entrepreneur whose research focuses on cellular biology and women’s health. Dr Weir’s groundbreaking product, invented and made here in Aotearoa New Zealand, uses a skin-based, non-hormonal combination of a hydrating cream and dietary supplement to support genital comfort, natural lubrication and urinary tract health – intimate issues that affect up to 84% of post-menopausal women. Dryness, irritation and discomfort in the vaginal area, are often dismissed as a natural part of ageing, leaving countless women to suffer in silence. Dr Weir, however, sees things differently.
“We’ve been conditioned to accept these changes as inevitable, but science tells us otherwise,” she explains. “Myregyna is designed to provide real support in this sensitive area, helping women maintain their quality of life and confidence in this new chapter.”
Developed through cutting-edge research, Myregyna is a skin-based, non-hormonal product that supports vaginal health before, during, and after menopause using natural, science-backed ingredients. At the centre of the breakthrough is Dr Weir’s proprietary and internationally patented ingredient Myrecil®, which supports the natural process of apoptosis – how the body disposes of damaged cells. Myrecil®Biome – a version developed specifically for gynaecology – powers the Myregyna postmenopausal support health system.
As well as Myrecil®Biome, Myregyna incorporates four essential probiotics to support a healthy urogenital microbiome. It can also be used alongside hormone replacement therapy (HRT). When the dual action cream and capsule system is used together, and as directed, noticeable support should be seen within two to four weeks.
To help amplify the conversation around the vaginal health issues women experience before, during and after menopause and the importance of addressing them openly, Robyn Malcolm has joined Weir Science as Myregyna’s ambassador. Known for her bold personality and advocacy for women, Malcolm sees this role as an opportunity to break stigmas and inspire change.
“Never having had an aptitude for science, I’m always in awe of scientists,” Malcolm says. “Iona has used her scientific genius (and it is genius), to create breakthrough support for women in the second half of their lives. It’s not about the hot flushes – it’s about what’s going on below, and it’s a game-changer!”
Malcolm’s passion for her new role stems from the belief that women deserve more than silence when it comes to their wellbeing. She aims to spark conversations and empower women to advocate for their health in this often taboo area.
Beyond the science, Myregyna also represents a larger cultural shift: the recognition that ageing doesn’t mean giving up on feeling good in your own skin. It’s about celebrating this new phase of life while shifting the focus to vitality and confidence.
Malcolm and Dr Weir hope to inspire a generation of women to embrace their health unapologetically. Through Myregyna, the message is clear: (peri)menopausal and post-menopausal women don’t need to accept discomfort or embarrassment as their new normal. With science and open conversations leading the way, they can take control of their wellbeing and thrive.
For more information about Myregyna, visit myregyna.co.nz. As well as online, Myregyna is available from Unichem, Life, and other selected pharmacies.
Always read the label and use as directed. If symptoms persist see your healthcare professional. Weir Science Ltd. TAPS PP3567.
